Formulation and Evaluation of the Pregabalin Immediate Release Microencapsulation Beadlets

Pregabalin is an effective drug used in the management of neuropathic pain and epilepsy; however, its conventional dosage forms may require frequent administration. The present study aimed to develop and evaluate pregabalin microencapsulated beadlets as a multiparticulate drug-delivery system capable of providing controlled drug release. Pregabalin beadlets were prepared using suitable encapsulation and pelletization techniques with selected pharmaceutical excipients. The prepared formulations were evaluated for percentage yield, particle size, flow properties, drug content, entrapment efficiency, surface characteristics, and in-vitro drug-release behavior. Fourier-transform infrared spectroscopy (FTIR) was performed to assess drug–excipient compatibility, and the characteristic peaks of pregabalin were retained in the physical mixture without significant changes, indicating compatibility. Among the developed formulations, the optimized formulation exhibited satisfactory physical characteristics, high drug content, and a controlled drug-release profile. The optimized formulation showed approximately 98% drug release over 12 h, demonstrating a gradual and sustained release pattern. The in-vitro release data were fitted to zero-order, first-order, Higuchi, and Korsmeyer–Peppas kinetic models. The Korsmeyer–Peppas model showed the highest correlation coefficient (R² = 0.982), suggesting that diffusion played a major role in drug release. Stability studies under accelerated conditions (40 ± 2°C/75 ± 5% RH) showed no significant changes in physical appearance, drug content, or drug-release characteristics during the study period. Overall, the developed pregabalin microencapsulated beadlets demonstrated satisfactory formulation characteristics and sustained drug-release behavior, indicating their potential as a multiparticulate controlled-release dosage form. Keywords: Microencapsulated beadlets; FTIR; Pregabalin; Korsmeyer–Peppas; Higuchi.

Authors

Publication Details

Journal
Journal of Drug Delivery and Therapeutics
Published
2026-11-15
DOI
https://doi.org/10.22270/jddt.v16i11.8052
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Formulation and Evaluation of the Pregabalin Immediate Release Microencapsulation Beadlets

Jyoti Gupta, Ram Babu Sharma, Bhav Saraswat
Journal of Drug Delivery and Therapeutics
Advanced Drug Delivery Systems
article

Formulation and Evaluation of the Pregabalin Immediate Release Microencapsulation Beadlets

Jyoti Gupta, Ram Babu Sharma, Bhav Saraswat
article en

Abstract

Pregabalin is an effective drug used in the management of neuropathic pain and epilepsy; however, its conventional dosage forms may require frequent administration. The present study aimed to develop and evaluate pregabalin microencapsulated beadlets as a multiparticulate drug-delivery system capable of providing controlled drug release. Pregabalin beadlets were prepared using suitable encapsulation and pelletization techniques with selected pharmaceutical excipients. The prepared formulations were evaluated for percentage yield, particle size, flow properties, drug content, entrapment efficiency, surface characteristics, and in-vitro drug-release behavior. Fourier-transform infrared spectroscopy (FTIR) was performed to assess drug–excipient compatibility, and the characteristic peaks of pregabalin were retained in the physical mixture without significant changes, indicating compatibility. Among the developed formulations, the optimized formulation exhibited satisfactory physical characteristics, high drug content, and a controlled drug-release profile. The optimized formulation showed approximately 98% drug release over 12 h, demonstrating a gradual and sustained release pattern. The in-vitro release data were fitted to zero-order, first-order, Higuchi, and Korsmeyer–Peppas kinetic models. The Korsmeyer–Peppas model showed the highest correlation coefficient (R² = 0.982), suggesting that diffusion played a major role in drug release. Stability studies under accelerated conditions (40 ± 2°C/75 ± 5% RH) showed no significant changes in physical appearance, drug content, or drug-release characteristics during the study period. Overall, the developed pregabalin microencapsulated beadlets demonstrated satisfactory formulation characteristics and sustained drug-release behavior, indicating their potential as a multiparticulate controlled-release dosage form. Keywords: Microencapsulated beadlets; FTIR; Pregabalin; Korsmeyer–Peppas; Higuchi.

Journal of Drug Delivery and TherapeuticsVol. 16(11)
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Formulation and Evaluation of the Pregabalin Immediate Release Microencapsulation Beadlets — Jyoti Gupta, Ram Babu Sharma, et al. · Journal of Drug Delivery and Therapeutics (2026) | TGRS Research Map | TGRS